TickerFacts.

Mereo BioPharma Group plc (MREO): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

797.12M
Year ended 2025-12-31
+9.7%
3-year compound annual growth
2022-12-31: 603.20M2023-12-31: 659.45M2024-12-31: 739.62M2025-12-31: 797.12M797.12M
2022-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31797.12M+7.8%2026-03-19, From 2025-01-01
2024-12-31739.62M+12.2%2026-03-19, From 2024-01-01
2023-12-31659.45M+9.3%2025-03-26, From 2023-01-01
2022-12-31603.20Mn/a2024-03-27, From 2022-01-01